Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

‘I don’t think the public are buying it’: Fallout from the Musqueam agreements

March 4, 2026

Corvus Robotics Deploys Autonomous Inventory System at Dermalogica Global Headquarters

March 4, 2026

Tiara Yachts Adds 46 LS to Its Luxury Sport Series

March 4, 2026

Prismatic Introduces AI Copilot to Enable End Users to Build Workflows with Natural Language

March 4, 2026

Introducing AI-Powered Creativity in CorelDRAW Graphics Suite 2026

March 3, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » AI Optical Coherence Tomography Market Opportunities to 2029 & 2034 by Type, Technology, Application and Region
Press Release

AI Optical Coherence Tomography Market Opportunities to 2029 & 2034 by Type, Technology, Application and Region

By News RoomJanuary 13, 20265 Mins Read
AI Optical Coherence Tomography Market Opportunities to 2029 & 2034 by Type, Technology, Application and Region
Share
Facebook Twitter LinkedIn Pinterest Email

Dublin, Jan. 13, 2026 (GLOBE NEWSWIRE) — The “Artificial Intelligence (AI) Optical Coherence Tomography (OCT) Market Report 2025” has been added to ResearchAndMarkets.com’s offering.

The artificial intelligence (AI) optical coherence tomography (OCT) market is on a trajectory of rapid growth, driven by technological advancements and a rising prevalence of ophthalmological diseases. Valued at $1.84 billion in 2024, it is projected to grow to $2.06 billion in 2025 at a CAGR of 12.3%, and further reach $3.25 billion by 2029 at a CAGR of 12%. Key factors propelling this growth include the increasing adoption of non-invasive diagnostic tools, expansion of hospital infrastructure, higher healthcare spending in developed nations, and broader reimbursement options.

A surge in the incidence of eye diseases, particularly driven by rising diabetes rates, underscores the market’s potential. AI-based OCT is pivotal in diagnosing eye conditions by delivering high-resolution retinal imaging for early detection and continuous monitoring, thus improving clinical efficiency. In May 2024, the CDC reported over 3 million Americans affected by glaucoma, a number expected to double by 2050, highlighting the significant role AI-OCT will play in the future.

Innovations in AI imaging, portable devices, and teleophthalmology solutions are shaping the market landscape. Notably, the introduction of at-home OCT devices is revolutionizing patient care, enabling remote monitoring and enhancing diagnostic accuracy. A case in point is Notal Vision Inc., which in May 2024 received FDA de novo authorization for its SCANLY Home OCT device, designed for self-operated retinal imaging to monitor wet age-related macular degeneration (AMD). This AI-powered device offers remote, high-resolution monitoring capabilities, which are seamlessly integrated into the healthcare system via secure data transmission to the cloud.

Strategic acquisitions are also shaping the competitive landscape. Topcon Healthcare Inc.’s acquisition of RetInSight GmbH enhances its AI-OCT capabilities and strengthens its digital eye care platform, promoting broader adoption of AI-driven retinal disease management technologies.

The market is dominated by players such as Abbott Laboratories, Canon Inc., Carl Zeiss AG, Topcon Corporation, and Notal Vision Inc. North America leads the market, with Asia-Pacific poised for the fastest growth. The geographic focus spans across key regions, including Asia-Pacific, Western Europe, North America, and others, with major markets in countries like the USA, China, and Japan.

However, fluctuating trade relations and tariffs pose challenges to the industry. The medical equipment sector, particularly its imported components, is affected by recent U.S. tariffs. Manufacturers are adopting strategies such as dual-sourcing and expanding domestic production to mitigate these risks.

Overall, the AI-OCT market is witnessing robust growth thanks to technological innovations, increased healthcare funding, and a rising demand for efficient diagnostic tools, paving the way for advancements in ophthalmology and beyond.

Report Scope

The report delves into the dimensions of the AI OCT market, identifying growth areas and key trends affecting its trajectory. It evaluates the market’s interaction with the global economy, demographic trends, and parallel markets, while also examining technological innovations, regulatory shifts, and changing consumer demands.

The analysis includes market characteristics, size, and growth forecasts, segmentation, regional and country breakdowns, competitive landscape, market shares, and strategy insights. Historical and predictive growth by geography is thoroughly mapped out.

  • Market characteristics and explanations.
  • Historical and forecast market size analysis covering financial performance, considering pertinent influences such as AI advancements, geopolitical dynamics, and fiscal variables.
  • In-depth market segmentation.
  • Regional and country-specific analysis outlining market magnitude and comparative growth statistics.
  • Competitor landscape highlighting market shares, leading companies, and significant financial transactions.
  • Strategic insights for navigating market evolution post-crisis.

Markets Covered:

  • By Type: Table Type; Portable
  • By Technology: Time Domain OCT; Spectral Domain OCT; Swept Source OCT
  • By Application: Hospitals; Clinics; Other Applications

Subsegments:

  • Table Type: SD-OCT; TD-OCT; SS-OCT; Full-Field OCT; Doppler OCT
  • Portable: Handheld OCT; Smartphone-based OCT; Point-Of-Care OCT; Compact OCT Units; Wearable OCT

Major Companies: Abbott Laboratories, Canon Inc., Carl Zeiss AG, Topcon Corporation, and others.

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Time Series: Analyzes five years of historical data with projections extending ten years into the future.

Data Insights: Provides ratios of market size to related markets, expenditure metrics, and comprehensive data segmentation across regions.

Delivery Format: The report is accessible in PDF, Word, and an Excel Data Dashboard for comprehensive insights.

Key Attributes

Report Attribute Details
No. of Pages 250
Forecast Period 2025-2029
Estimated Market Value (USD) in 2025 $2.06 Billion
Forecasted Market Value (USD) by 2029 $3.25 Billion
Compound Annual Growth Rate 12%
Regions Covered Global

The companies featured in this Artificial Intelligence (AI) Optical Coherence Tomography (OCT) market report include:

  • Abbott Laboratories
  • Canon Inc.
  • Carl Zeiss AG
  • Excelitas Technologies Corp.
  • Topcon Corporation
  • Thorlabs Inc.
  • Santec Holdings Corporation
  • Notal Vision Inc.
  • Optopol Technology Sp. z o.o.
  • BigVision Tech Inc.
  • Shenzhen Certainn Technology Co. Ltd.
  • Conavi Medical Inc.
  • Wasatch Photonics Inc.
  • RSIP Vision Ltd.
  • Visionix Ltd.
  • Altris AI Ltd.
  • NIDEK Co. Ltd.
  • Perimeter Medical Imaging AI Inc.
  • Michelson Diagnostics Ltd.
  • Artelus Private Limited

For more information about this report visit https://www.researchandmarkets.com/r/28waqh

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

  • Artificial Intelligence (AI) Optical Coherence Tomography (OCT) Market

            
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Corvus Robotics Deploys Autonomous Inventory System at Dermalogica Global Headquarters

Tiara Yachts Adds 46 LS to Its Luxury Sport Series

Prismatic Introduces AI Copilot to Enable End Users to Build Workflows with Natural Language

Introducing AI-Powered Creativity in CorelDRAW Graphics Suite 2026

Mary Kay® Unmasks the Possibilities of All-Day Glow and Long-Lasting Moisture With New No-Rinse Hydrating Cream Mask

SDM SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Smart Digital (SDM) Investors of Securities Class Action Deadline on March 16, 2026

HELE SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Helen of Troy (HELE) Investors of Securities Class Action Deadline on March 2, 2026

Data Center Networking Technology Global Markets Report 2025-2030, Profiles of Leading Players – Cisco Systems, Dell, Broadcom, Arista Networks, and Hewlett Packard Enterprise

VRNS SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Varonis Systems (VRNS) Investors of Securities Class Action Deadline on March 9, 2026

Editors Picks

Corvus Robotics Deploys Autonomous Inventory System at Dermalogica Global Headquarters

March 4, 2026

Tiara Yachts Adds 46 LS to Its Luxury Sport Series

March 4, 2026

Prismatic Introduces AI Copilot to Enable End Users to Build Workflows with Natural Language

March 4, 2026

Introducing AI-Powered Creativity in CorelDRAW Graphics Suite 2026

March 3, 2026

Latest News

Mary Kay® Unmasks the Possibilities of All-Day Glow and Long-Lasting Moisture With New No-Rinse Hydrating Cream Mask

March 3, 2026

Calgary needs an extra $609M for Bearspaw feeder main, water infrastructure upgrades

March 3, 2026

SDM SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Smart Digital (SDM) Investors of Securities Class Action Deadline on March 16, 2026

March 3, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version